Traditional Chinese Medicine Hebei Lerentang

Hebei Lerentang Pharmaceutical is a venerable Chinese pharmaceutical enterprise specializing in the development and manufacture of Traditional Chinese Medicine (TCM). Established as part of the historic Lerentang lineage, the company was acquired by Shijiazhuang Yiling Pharmaceutical in 2011. Its flagship product, Shu-Xue-Tong Injection, is a widely utilized treatment for cardiovascular and cerebrovascular diseases in China. The company's portfolio spans multiple therapeutic areas, including respiratory health, gastroenterology, and gynecology. Hebei Lerentang operates modern, GMP-certified production lines and continues to integrate traditional herbal knowledge with contemporary pharmacological standards.